Health Condition 1: K259- Gastric ulcer, unspecified as acute or chronic, without hemorrhage or perforation
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients of either gender in the age group between 18 -85 years 2. Patients having Symptoms of Digestive system disorders 3. Willing to enrol in study by signing Informed consent
Exclusion criteria
Exclusion criteria: 1. Earlier participation in this study 2. Patients having other systemic diseases not under control 3. Patients who are not willing to sign the informed consent form 4. Patients who are diagnosed with malignancies 5. Post-surgical cases 6. Patients with severe symptoms of acute onset 7. Unable to respond properly for questionnaire or when a patient is too severely ill to answer the questions
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Any incidents of adverse events after the administration of Anticid Liquid. Any marked change in safety parameters measured during the administration of the product Reporting the effectiveness of this product in the management of GI disorders and associated complaints Timepoint: Assessment parameters will be assessed on 0th day, 15th day, 30th day, and 45th day. If symptoms subsided on 15th day, follow up assessment will be done on 30th day. | — |
Secondary
| Measure | Time frame |
|---|---|
| Additional therapeutic advantages of the productTimepoint: Assessment parameters will be assessed on 0th day, 15th day, 30th day, and 45th day. If symptoms subsided on 15th day, follow up assessment will be done on 30th day. | — |
Countries
India
Contacts
Pankajakasthuri Herbal research Foundation